| 2025-11-12 |
详情>>
股本变动：
变动后总股本5436.03万股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.22美元,归母净利润926.90万美元,同比去年增长9.12%
|
| 2025-11-12 |
财报披露：
美东时间 2025-11-12 盘前发布财报
|
| 2025-08-18 |
详情>>
内部人交易：
JASKOLSKI ANGELA MARIE股份增加125000.00股
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益0.13美元,归母净利润548.70万美元,同比去年增长-23.01%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益0.04美元,归母净利润173.50万美元,同比去年增长-38.5%
|
| 2025-04-18 |
股东大会：
将于2025-06-03召开股东大会
会议内容 ▼▲
- 1.Election of the two director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ended January 3, 2026;
3.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2025-03-11 |
复牌提示：
2025-03-11 09:30:20 停牌，复牌日期 2025-03-11 09:45:20
|
| 2025-03-11 |
详情>>
业绩披露：
2024年年报每股收益0.22美元,归母净利润1046.20万美元,同比去年增长17.14%
|
| 2025-03-11 |
详情>>
业绩披露：
2022年年报每股收益0.19美元,归母净利润730.80万美元,同比去年增长314.00%
|
| 2024-11-15 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.18美元,归母净利润849.40万美元,同比去年增长31.79%
|
| 2024-08-14 |
详情>>
业绩披露：
2023年中报每股收益0.06美元,归母净利润350.40万美元,同比去年增长22.82%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益0.15美元,归母净利润712.70万美元,同比去年增长103.40%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益0.06美元,归母净利润282.10万美元,同比去年增长655.31%
|
| 2024-04-19 |
股东大会：
将于2024-06-04召开股东大会
会议内容 ▼▲
- 1.Election of the two director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ended January 4, 2025;
3.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2024-03-06 |
详情>>
业绩披露：
2023年年报每股收益0.17美元,归母净利润893.10万美元,同比去年增长22.21%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.12美元,归母净利润644.50万美元,同比去年增长1.10%
|
| 2023-04-21 |
股东大会：
将于2023-05-10召开股东大会
会议内容 ▼▲
- 1.As a special resolution, to amend and restate the Company’s Amended and Restated Memorandum and Articles of Association (the “Charter”) pursuant to an amended and restated Charter in the form set forth in Annex A of the accompanying proxy statement to extend the date by which we must (1) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (an “initial business combination”), (2) cease our operations except for the purpose of winding up if we fail to complete such initial business combination, and (3) redeem all of the Class A ordinary shares, par value $0.0001 per share, of the Company (“Class A Ordinary Shares” or “public shares”) included as part of the units sold in our initial public offering that was consummated on November 12, 2021 (the “IPO”), from May 12, 2023 to November 12, 2023 (the “Extended Date”) and to allow the board of directors of the Company (the “Board”), without another shareholder vote, to elect to further extend the date to consummate an initial business combination after the Extended Date up to three times, by an additional month each time, upon two days’ advance notice prior to the applicable deadline, up to February 12, 2024 (the “Additional Extension Date” and together with the Extended Date the “Extension” and such proposal, the “Extension Proposal”);
2.As an ordinary resolution, to approve the adjournment of the Extraordinary General Meeting to a later date or dates, if necessary or convenient, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Proposal (the “Adjournment Proposal”), which will only be presented at the Extraordinary General Meeting if, based on the tabulated votes, there are not sufficient votes at the time of the Extraordinary General Meeting to approve the Extension Proposal, in which case the Adjournment Proposal will be the only proposal presented at the Extraordinary General Meeting.
|
| 2023-04-21 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.Election of the three director nominees named in the Proxy Statement to serve until the 2026 annual meeting of stockholders;_x000D_
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ended January 6, 2024;_x000D_
3.Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of officers of the Company;_x000D_
4.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2022-04-22 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.Election of the two director nominees named in the Proxy Statement to serve until the 2025 annual meeting of stockholders;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ended December 31, 2022;
3.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|